These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19649375)

  • 21. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.
    Hasnain M; Fredrickson SK; Vieweg WV
    J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of weight gain in patients with schizophrenia.
    Aquila R
    J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of obesity in children with psychiatric disorders taking atypical antipsychotics.
    Shin L; Bregman H; Frazier J; Noyes N
    Harv Rev Psychiatry; 2008; 16(2):69-79. PubMed ID: 18415880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain.
    Vandyk AD; Baker C
    Int J Ment Health Nurs; 2012 Aug; 21(4):349-57. PubMed ID: 22404848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight gain profiles of new anti-psychotics: public health consequences.
    Tardieu S; Micallef J; Gentile S; Blin O
    Obes Rev; 2003 Aug; 4(3):129-38. PubMed ID: 12916814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of antipsychotic-associated weight gain.
    O'Keefe CD; Noordsy DL; Liss TB; Weiss H
    J Clin Psychiatry; 2003 Aug; 64(8):907-12. PubMed ID: 12927005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions to reduce weight gain in schizophrenia.
    Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005148. PubMed ID: 17253540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity in schizophrenia: what can be done about it?
    Catapano L; Castle D
    Australas Psychiatry; 2004 Mar; 12(1):23-5. PubMed ID: 15715734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic syndrome induced by antipsychotic drugs. The problem of obesity].
    Jufe GS
    Vertex; 2008; 19(82):338-47. PubMed ID: 19424516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
    Park T; Usher K; Foster K
    Int J Ment Health Nurs; 2011 Dec; 20(6):428-37. PubMed ID: 21564457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
    Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB
    J Psychopharmacol; 2007 Jun; 21(4):357-73. PubMed ID: 17656425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic risks and effects of atypical antipsychotic treatment.
    Haupt DW; Kane JM
    J Clin Psychiatry; 2007 Oct; 68(10):e24. PubMed ID: 17960957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Wellness-activities to prevent metabolic syndrome among patients with schizophrenia].
    Brönner M; Betz C; Christ S; Froböse T; Pitschel-Walz G; Bäuml J
    Psychiatr Prax; 2010 Jan; 37(1):7-19. PubMed ID: 19672818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.
    Nyboe L; Lemcke S; Møller AV; Stubbs B
    Psychiatry Res; 2019 Nov; 281():112556. PubMed ID: 31521840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.